Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region
16/06/2026 02:48
BRIEF-Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region June 16 (Reuters) - Dimerix Ltd DXB.AX:
DIMERIX LICENSES DMX200 TO EVEREST FOR CHINA AND ASIA REGION
Further company coverage: DXB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Everest Medicines
See all newsBrief: Everest Medicines Says NMPA Approves Cardamyst (Etripamil) NDA For PSVT In Adults In China
Brief: Everest Medicines Enters Commercialization Collaboration With Hainan Herui Pharmaceutical
Brief: Everest Medicines Says CBC Group Purchases 712,000 Everest Medicines Shares For Hk$19.2 Million From 16 To 17 June
Australia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region